Mayne Pharma | MYX - Aktiva

Keuangan

AUD

AUD 1.14B

AUD 110.07M

Biaya Penjualan

AUD 43.74M

AUD 460.59M

Kewajiban Lancar

AUD 313.94M

AUD 38.82M

AUD -16.2M

AUD 20.9M

450

Eps Laba Per Saham

AUD -0.15

Modal Dan Cadangan

AUD 454.19M

Laba Kotor Pada Penjualan

AUD 86.13M

Beban Bunga Utang

AUD 1.2M

AUD 2.66M

Kapitalisasi Pasar

AUD 230.55M

Batas Pemasukan

AUD -103.68M

Biaya Operasional

AUD 103.54M

Laba Operasional

AUD -3.3M

Modal Saham Biasa

AUD 81.25M

Laba Sebelum Pajak

AUD -14.7M

Pendapatan Penjualan

AUD 212.07M

Beban Penjualan Dan Administrasi

AUD 54.8M

AUD 74.63M

Kreditur Perdagangan

AUD 30.25M

Debitur Perdagangan

AUD 193.22M

	Aktiva	Perubahan		Tanggal
Ansell	USD 3.33B		3.2M	2025-12
Avita Medical	AUD 56.39M		1.74M	2025-12
Cochlear	AUD 2.79B		31.3M	2025-12
CSL	USD 37.9B		1.5B	2025-12
Healius	AUD 3.07B		84.2M	2024-12
Integral Diagnostics	AUD 744.28M		1.52M	2024-06
Medical Developments International	AUD 63.57M		2.83M	2025-12
Nanosonics	AUD 279.25M		6.77M	2025-12
Polynovo	AUD 123.37M		4.04M	2025-12
Ramsay Health Care	AUD 21.7B		777.8M	2025-12
ResMed	USD 8.78B		280.91M	2026-03
Sigma Healthcare	AUD 8.29B		6.91B	2025-12
Sonic Healthcare	AUD 15.38B		550.57M	2024-12
Telix Pharmaceuticals	AUD 1.16B		25.97M	2025-12